Feasibility of Voiding Cycle Ambulatory Monitorization: beyond home uroflowmetry.

Batista-Miranda J1, Corrales-Acosta2, Malizia3, Bassas-Parga4, Cuny5, Arenas-Aquino A6

Research Type


Abstract Category

Research Methods / Techniques

Abstract 574
Open Discussion ePosters
Scientific Open Discussion Session 34
Saturday 10th September 2022
13:20 - 13:25 (ePoster Station 6)
Exhibition Hall
New Devices Urodynamics Techniques Voiding Dysfunction Voiding Diary Pediatrics
1. Centro Medico Teknon / URD centers, 2. Centro Médico Teknon/ URD center, 3. Centor Médico Teknon / URD centers, 4. Centro Medico Teknon / URD centers, 5. Centro Médico Teknon/ URD Centers, 6. Urodex Barcelona

JE Batista-Miranda




Hypothesis / aims of study
Uroflowmetry is an essential tool for assessing voidingn phase problems. It  has evolved greatly due to technological advances (1) and home uroflowmetry (HU) is available in different versions (2,3)  .
Minze HomeFlow  ( MINZE | Health,  Antwerp, Belgium) is an HU that automatically registers voiding volume at an exact time, connected to an online app using BlueTooth technology. Its design is user firiendly and voiding assesment can be performed in children and adults, both male and female. Collected data are processed on the cloud-based Minze Clinician Portal accessible to physicians in real-time. It can be used anywhere, though it´s preferable in the home setting. 
Minze HomeFlow device allows to  monitoring remotely patients´ micturition cycle, following a natural bladder filling and giving them autonomy to do the things they know cause their symptoms from experience. Lockdown due to Covid-19 increased our use of the system, given patients´  reluctance to undergo full urodynamic studies. 
We aim to  audit the pioneering experience with this device in adult and pediatric populations,  and its feasibility and indications in a functional urology clinic. Data from Qmax, Void Vol, hour and date provided a Voiding Cycle Ambulatory Monitorization (VCAM)
Study design, materials and methods
A retrospective descriptive study of the first patients who were given the Minze HomeFlow device  in a functional urology consultation was performed.  Medical history, previous urodynamic studies and all traces produced where analized.  Informed consent was obtained in all patients.
The device was given to 73 patients in the period between May 2019 and February 2022. 12 were children and 61 adults.  We excluded twelve patients with incomplete readings ( less than 48h  or less than 50% registred voidings)  or unable  to use the equipment ( feasibility 83%). 
61 patients provided good readings for analysis: 11 were children- mean age 8, yrs, and 50 adults -mean age 48 yrs . The indication in children was enuresis and voiding dysfunction. Only one child had previous urodynamics, and  4  rejected catheterization during scheduled urodynamics. 
The main indications in adults were voiding dysfunction, hyperactive bladder and nocturia ( Table 1) 

Each patient´s data  were analyzed according to sex, age, the reason for use, days of device use, and uroflowmetry parameters.
The range of days recorded ranged from 2 to 14 days, with a total of 311 days recorded ( average of 5 days/ patient) and a total of 1954 micturitions ( average  32 voids / patient). At least  8 voids and 2 days were recorded,  but most patients produced more than 15 good quality readings over 3 days. Incomplete studies were more common in the first months of use and in the elderly patients.  

The uroflowmetry parameters obtained in adults included a mean urinary volume of 170.4 ml (range 40-413 ml) and a mean maximum urine flow rate (Qmax) of 15.4 ml/s. In children, the mean volume was 98.2 ml (range 21 to 210 ml), and the mean Qmax was 15ml/s. (Table 2)

Diagnostic contribution: 
CHILDREN: in all patients,  VCAM enabled to consistently determine low capacity bladder in the absence of voiding dysfunction and thus, anticholinergic therapy could be started without the need of catheterization. Aside from the children who refused urodynamics, the rest of the parents and children decided not to undergo a full study once offered the possibility of a non - invasive test.
ADULTS:  Voiding dysfunction  was confirmed in patients with variable patterns or unable to void in hospital (shy bladder syndrome); low capacity bladder and normal was confirmed in patients with suspected OAB; in some patients with nocturia the coexistence of bladder obstruction was seen. 
There were no complications with the use of this device.
Interpretation of results
VCAM by means of Home uroflowmetry provides the ability to analyze a great number of  uroflowmetry readings and thus , a more accurate assessment. (2) Additionally, the hesitation that a patient may have due to the “white-coat” influence on micturition is significantly minimized in children and in many adults (3).  Patients´ ability to use the device has increased in the last months, due to technical improvements and our ability to explain the procedure. 
The main diagnostic contribution in children was the study of the low-capacity bladder with normal emptying and in adults the complete assessment of the emptying phase. Other conditions that can co- exist with nocturia can also be assesed ( obstruction, low capacity). The system provides a non-invasive user-friendly diagnosis in many conditions.  Despite pressure can´t be measured, voided volumes and time provide a good indirect measure of filling phase.  Additionally, it provides an indirect measurement of patient motivation and adherence.  
This initial experience will enable us to offer this system to more patients and more acurately define its indications.
Concluding message
VCAM / HU is already a feasable and challenging diagnostic tool that can provide significant information in many patients.  Further studies will help us define wider indications.
Figure 1 Table 1. Indications for perfoming VCAM in patients with complete readings.
Figure 2 Table 2. Results of the study population
  1. Chancellor MB, Rivas DA, Mulholland SG, Drake WM Jr. The invention of the modern uroflowmeter by Willard M. Drake, Jr at Jefferson Medical College. Urology. 1998 Apr;51(4):671-4.
  2. Boci R, Fall M, Waldén M, Knutson T, Dahlstrand C. Home uroflowmetry: Improved accuracy in outflow assessment. Neurourol Urodyn. 1999;18(1):25–32.
  3. Porru D, Scarpa RM, Prezioso D, Bertaccini A, Rizzi CA. Home and office uroflowmetry for evaluation of LUTS from benign prostatic enlargement. Prostate Cancer Prostatic Dis. 2005;8(1):45–9.
Funding None Clinical Trial No Subjects Human Ethics not Req'd The study is a clinical audit, approved by patients following Barcelona Medical College recommendations. Helsinki Yes Informed Consent Yes
19/09/2023 10:23:44